BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 20, 2016
View Archived Issues
EMA issues positive opinion on the MAA for SomaKit TOC
Read More
Heidelberg Pharma signs option agreement with the Max Delbruck Center for BCMA antibodies
Read More
Enrollment open in phase I trial of HS-10241 in solid tumors
Read More
Grant supports Garvan Institute of Medical Research's purchase of Chromium Genome Solution
Read More
Shanghai Institute Materia Medica patents anticancer agents
Read More
Phase II study of CMV vaccine ASP-0113 in kidney transplant patients does not meet primary endpoint
Read More
FDA approves Kyleena for prevention of pregnancy for up to 5 years
Read More
KemPharm submits IND application to commence clinical trials of KP-415
Read More
Eli Lilly discloses GPR142 agonists
Read More
Bristol-Myers Squibb and Rigel Pharmaceuticals describe TGF-beta1 inhibitors
Read More
PRIDE-HD study demonstrates statistically significant impact on disease progression at 52 weeks
Read More
Evgen's SFX-01 shows promise in preclinical MS model
Read More
SUSTAIN-6 finds reduced cardiovascular outcomes with semaglutide in type 2 diabetes patients
Read More
Prexton Therapeutics completes phase I study of lead compound for Parkinson's disease
Read More
Siponimod reduces the risk of MS disability progression
Read More
ARN-6039 safe in phase I trial
Read More
FDA grants accelerated approval to Exondys 51 for Duchenne muscular dystrophy
Read More
XOMA updates status of phase II trials of XOMA-358 in severe hypoglycemia
Read More
Testing of IRX-4204 in preclinical MS model shows promising results
Read More
NovaBay Pharmaceuticals' Auriclosene Irrigating Solution shows positive results in phase IIb study
Read More
FDA grants fast track designation to SELLAS' galinpepimut-S
Read More
PSP/reg shows promise as an assistive biomarker for the diagnosis of DN
Read More
GUB09-145 exerts marked effects on HbA1c, body weight and glucose homestasis in mice
Read More
FDA awards fast track status to Aerosurf for RDS
Read More
BioArctic and AbbVie collaborate on Parkinson's disease
Read More
Cantargia outlines plans for CAN-04 development
Read More